Prothena
PRTA
#7581
Rank
NZ$0.71 B
Marketcap
NZ$13.63
Share price
-6.61%
Change (1 day)
56.43%
Change (1 year)

Market capitalization of Prothena (PRTA)

Market cap: NZ$0.71 Billion

As of June 2026 Prothena has a market cap of NZ$0.71 Billion. This makes Prothena the world's 7581th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Prothena from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.71 B-19.52%
2025NZ$0.88 B-38.62%
2024NZ$1.44 B-53.16%
2023NZ$3.08 B-37.05%
2022NZ$4.89 B45.38%
2021NZ$3.36 B407.13%
2020NZ$0.66 B-29.14%
2019NZ$0.93 B53.21%
2018NZ$0.61 B-69.84%
2017NZ$2.02 B-17.13%
2016NZ$2.44 B-22.47%
2015NZ$3.15 B335.32%
2014NZ$0.72 B2.88%
2013NZ$0.70 B347.77%
2012NZ$0.15 B

End of Day market cap according to different sources

On Jun 10th, 2026 the market cap of Prothena was reported to be:

NZ$0.71 Billion
by Nasdaq info icon info icon
NZ$0.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amarin Corporation
AMRN
NZ$0.53 B-25.26%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
NZ$67.00 B 9,289.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$12.59 B 1,664.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland